Emergent BioSolutions (EBS) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.25 -0.36%
Revenue Growth %: +32.0%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +32.0%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $2.19, $0.07 better than the analyst estimate of $2.12. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $437.93 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
- Incyte acquires Vega Therapeutics for $1.25B upfront
- ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
